Company Performance: Samsung Biologics' financial health, including revenue, profit margins, and debt levels, significantly impacts its stock price. Positive earnings reports usually lead to price increases.

Industry Trends: Developments in the biopharmaceutical industry, such as new drug approvals, regulatory changes, and technological advancements, influence investor sentiment towards Samsung Biologics.

Overall Market Conditions: Broad economic factors like interest rates, inflation, and global economic growth affect investor confidence and the overall stock market, including Samsung Biologics.

Competitor Activities: Actions by rival companies, such as capacity expansions or contract wins, can impact Samsung Biologics' perceived market share and future prospects, thereby affecting its stock price.

Regulatory Environment: Changes in regulations related to drug manufacturing, healthcare, and environmental standards can affect Samsung Biologics' costs and operations, influencing investor confidence.

Investor Sentiment: General market sentiment and investor expectations, often driven by news and analyst ratings, play a role in short-term stock price fluctuations.

Contract Manufacturing Agreements: The volume and value of contract manufacturing agreements (CMAs) Samsung Biologics secures with pharmaceutical companies have a direct impact on its revenue projections and stock price.

Capacity Expansion Plans: Announcements regarding new facility construction or capacity expansions can signal future growth and potentially boost the stock price, though execution risk must be considered.

Global Health Crises: Events like pandemics or significant disease outbreaks can impact demand for biopharmaceutical products and services, affecting Samsung Biologics' performance and stock value.